Company profile

DNAnexus

Precision Medicine & Genomics

Company profile

About DNAnexus

DNAnexus operates the Precision Health Data Cloud, a comprehensive platform trusted by hundreds of biomedical organizations worldwide to accelerate scientific discovery and improve patient care. The company provides an enterprise-grade cloud infrastructure that enables pharmaceutical companies, academic medical centers, clinical diagnostics labs, biobanks, and population health programs to manage, analyze, and collaborate on multiomics and multimodal precision health data. The DNAnexus Platform breaks down data silos by creating a single source of truth for genomic, clinical, and other biomedical data types. It offers rapid workflow development with support for multiple bioinformatics languages including Nextflow and WDL, pre-built tools and apps, and seamless integration with existing technology ecosystems including sequencers and R&D applications. The platform features AI and machine learning capabilities for predictive analytics, cohort analysis tools, integrated JupyterLab notebooks, and data visualization applications. DNAnexus serves the entire precision medicine lifecycle from research through clinical diagnostics, with specialized solutions including Innovation Hubs, NGS Data Analysis, Translational Informatics, Population Genomics, and Trusted Regulatory Spaces for regulatory submissions. The company maintains partnerships with major cloud providers and technology partners, and powers large-scale initiatives including the UK Biobank Research Analysis Platform. With regulatory-grade security and compliance certifications, DNAnexus enables organizations to scale on-demand while maintaining data governance and supporting global regulatory collaboration.

Company description DNAnexus official website

Primary marketPrecision Medicine & Genomics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at DNAnexus?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • ALS (Longitude Prize)
  • Cancer (adaptive cancer treatment via ARPA-H)
  • General precision medicine and genomics applications
  • Multiple Sclerosis (Accelerated Cure Project)

Who it serves

  • Academic Medical Centers
  • Biobanks & Population Programs
  • Clinical Diagnostics
  • Commercial Data Businesses
  • Pharmaceutical & Biotech
  • Regulatory agencies

Deployment & integration

Cloud Saas deployment with recorded integration context.

Recorded integration context: EHR systems, Epic, Oracle, R&D lifecycle applications, Sequencers.

Geographic context

MarketsGlobal · United Kingdom · United States
Company sourceOfficial website

Company milestones

Platform expansion

DNAnexus and Oracle partnership to link genomic data to EHRs; ARPA-H adaptive cancer treatment program; World's largest single-cell dataset available on platform; EpiCypher CUTANA Cloud launch; Accelerated Cure Project for MS Data Challenge Pilot; Longitude Prize Discovery Team selections; Boehringer Ingelheim Prix Galien USA finalist

Partnerships

Recorded partners

  • Accelerated Cure Project for MS
  • ARPA-H
  • Boehringer Ingelheim
  • Cloud Partners
  • Data & Biobank Partners
  • EpiCypher
  • Instrument Partners
  • Longitude Prize on ALS
  • Myriad Genetics
  • Oracle
  • Services Partners
  • Technology Partners
  • UK Biobank

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

CUTANA Cloud

EpiCypher's CUT&RUN/Tag epigenomics analysis platform powered by DNAnexus

Platform · Cloud SaaSCompany source

DNAnexus Platform

The world's most trusted platform for precision health where multiomic data and AI converge

Platform · Cloud SaaSCompany source

Innovation Hub

Solution for accelerating biomedical innovation and scientific discovery

Platform · Cloud SaaSCompany source

NGS Data Analysis

Next-generation sequencing data analysis solution with pre-built bioinformatics tools

Software · Cloud SaaSCompany source

Population Genomics

Large-scale population genomics analysis and biobank data management solution

Platform · Cloud SaaSCompany source

precisionFDA Collaborative Omics Environment

FDA-powered collaborative platform for sponsor-reviewer interaction and multi-omics analysis

Platform · Cloud SaaSCompany source

Translational Informatics

Bridge research and clinical applications with integrated multiomics and clinical data

Platform · Cloud SaaSCompany source

Trusted Regulatory Spaces (TRS)

Cloud-based regulatory collaboration framework for life sciences compliance and submission

Platform · Cloud SaaSCompany source

UK Biobank Research Analysis Platform

Dedicated research analysis platform for UK Biobank data access and analysis

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

395% ROI

Return on investment for DNAnexus customers

40% reduction

Time spent deploying new bioinformatics pipelines

Over 1 year saved

Immediate time-to-value vs DIY environments that take over a year to build

Boehringer Ingelheim

Cloud transformation through Trusted Regulatory Spaces for regulatory intelligence and policy

2025 Prix Galien USA finalist

Accelerated Cure Project for MS

Launching ACP Data Challenge Pilot for multiple sclerosis research

ARPA-H

Pioneering game-changing adaptive cancer treatment research

EpiCypher

Launching CUTANA Cloud for CUT&RUN/Tag epigenomics analysis

FDA

Powering precisionFDA Collaborative Omics Environment for enhanced sponsor-reviewer interaction and multi-omics support

Myriad Genetics

Scaling genomic testing operations to impact patient outcomes

UK Biobank

Enabling precision medicine research with world's largest biobank dataset

World's largest single-cell dataset available

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

06 · Company updates

Updates from DNAnexus

Recent articles published on DNAnexus's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Precision Medicine & Genomics

Companies using AI to analyze genomic, proteomic, metabolomic, or multi-omics data to provide personalized treatment recommendations, identify genetic risks, or develop targeted therapies. Includes genomic sequencing platforms with AI analysis, preventive medicine based on genetic risk assessment, and longevity care based on molecular and genetic data.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon